PRESTIGE CONSUMER HEALTHCARE INC. Operating Leases, Future Minimum Payments, Due in Four Years
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.79 million as of 2019-03-31, per its 10-K filed 2020-05-08.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-05-08
- 2019-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.79M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $2.19M.
- 2017-03-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.46M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.93M.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2019-03-31 | $1.79M 10-K · filed 2020-05-08 |
| 2018-03-31 | $2.19M 10-K · filed 2018-05-10 |
| 2017-03-31 | $1.46M 10-K · filed 2017-05-17 |
| 2016-12-31 | $1.93M 10-Q · filed 2017-02-02 |
| 2016-09-30 | $1.94M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.84M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.76M 10-K · filed 2016-05-17 |
| 2015-12-31 | $1.93M 10-Q · filed 2016-02-04 |
| 2015-09-30 | $1.86M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.86M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $1.86M 10-K · filed 2015-05-14 |
| 2014-12-31 | $1.86M 10-Q · filed 2015-02-05 |
| 2014-09-30 | $1.86M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $1.42M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $1.04M 10-K · filed 2014-05-19 |
| 2013-12-31 | $1.09M 10-Q · filed 2014-02-07 |
| 2013-09-30 | $1.09M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $1.09M 10-Q · filed 2013-08-01 |
| 2013-03-31 | $1.09M 10-K · filed 2013-05-17 |
| 2012-12-31 | $1.13M 10-Q · filed 2013-02-07 |
| 2012-09-30 | $1.13M 10-Q · filed 2012-11-07 |
| 2012-06-30 | $991.00K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |